Target Name: MIR380
NCBI ID: G494329
Review Report on MIR380 Target / Biomarker Content of Review Report on MIR380 Target / Biomarker
MIR380
Other Name(s): hsa-miR-380-3p | mir-380 | MIRN380 | MicroRNA 380 | MIR380-3p | microRNA 380 | hsa-miR-380-5p | hsa-mir-380

MIR380: A Potential Drug Target and Biomarker

MIR380 (hsa-miR-380-3p), a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate.

MIR380 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in various tissues and cells throughout the body and is involved in the regulation of gene expression, cell growth, and differentiation.

One of the unique features of MIR380 is its structure. It has a unique double-stranded structure, with a core loop region and a stem-loop region at the 5' end. The core loop region is composed of 19 base pairs and is the most conserved region in MIR380. The stem-loop region is composed of seven base pairs and is the region where MIR380 interacts with other molecules.

MIR380 has been shown to play a role in the regulation of various genes, including cancer-related genes. For example, MIR380 has been shown to repress the expression of the gene encoding the protein PDGF-BB, which is a potent cancer-promoting factor. Additionally, MIR380 has been shown to promote the degradation of the gene encoding the protein NF-kappa-B, a transcription factor that can lead to the expression of cancer-related genes.

MIR380 has also been shown to be involved in the regulation of cellular processes that are important for cancer progression. For example, MIR380 has been shown to play a role in the regulation of cell migration and the association with the protein T-cell receptor (TCR), which is a critical regulator of immune responses and has been implicated in cancer progression.

In addition to its potential role in cancer, MIR380 has also been shown to be involved in the regulation of other diseases. For example, MIR380 has been shown to play a role in the regulation of stem cell proliferation and the development of cancer. Additionally, MIR380 has been shown to be involved in the regulation of the production of platelets, which are important for blood clotting and have been implicated in various diseases, including heart disease and cancer.

Given its unique structure and function, MIR380 has generated a lot of interest among researchers as a potential drug target and biomarker. Studies have shown that MIR380 can be effectively targeted with small molecules, including inhibitors of the miRNA-protein interaction. Additionally, MIR380 has been shown to have a high degree of sequence diversity, which makes it a promising target for individualized therapy.

In conclusion, MIR380 is a non-coding RNA molecule that has unique structure and function. Its potential as a drug target and biomarker has generated a lot of interest among researchers and has the potential to lead to new treatments for various diseases. Further research is needed to fully understand the role of MIR380 in the regulation of various genes and to develop effective strategies for targeting it for therapeutic purposes.

Protein Name: MicroRNA 380

The "MIR380 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR380 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287